XML 21 R5.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Follow-on Public Offering
Common Stock
Additional Paid-In Capital
Follow-on Public Offering
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Follow-on Public Offering
Total
Balance at Dec. 31, 2024   $ 7   $ 430,859 $ (1,288) $ (397,010)   $ 32,568
Balance (in shares) at Dec. 31, 2024   67,899,779            
Common stock issued upon exercise of stock options       279       279
Common stock issued upon exercise of stock options (in shares)   269,682            
Stock-based compensation expense       1,251       1,251
Unrealized loss on marketable securities         (23)     (23)
Foreign currency translation adjustment         57     57
Net income (loss)           15,193   15,193
Balance at Mar. 31, 2025   $ 7   432,389 (1,254) (381,817)   49,325
Balance (in shares) at Mar. 31, 2025   68,169,461            
Balance at Dec. 31, 2025   $ 7   474,387 (896) (412,293)   $ 61,205
Balance (in shares) at Dec. 31, 2025   74,696,629           74,696,629
Common stock issued upon exercise of stock options       1,339       $ 1,339
Common stock issued upon exercise of stock options (in shares)   308,017            
Common stock issued $ 1   $ 189,406       $ 189,407  
Common stock issued (in shares) 9,085,778              
Stock-based compensation expense       2,650       2,650
Unrealized loss on marketable securities         (334)     (334)
Foreign currency translation adjustment         104     104
Net income (loss)           (13,692)   (13,692)
Balance at Mar. 31, 2026   $ 8   $ 667,782 $ (1,126) $ (425,985)   $ 240,679
Balance (in shares) at Mar. 31, 2026   84,090,424           84,090,424